NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Giulia Siravegna
Harvard University - Cambridge / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1352356
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Giulia Siravegna's MOST POPULAR ARTICLES
1-)
Detection of circulating tumor DNA in early-and late-stage human malignanciesC Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...Science translational medicine 6 (224), 224ra24-224ra24, 201438932014
2-)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerS Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ...Nature 486 (7404), 532-536, 201218282012
3-)
Integrating liquid biopsies into the management of cancerG Siravegna, S Marsoni, S Siena, A BardelliNature reviews Clinical oncology 14 (9), 531-548, 201713862017
4-)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsG Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...Nature medicine 21 (7), 795-801, 201511202015
5-)
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of …A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ...The Lancet Oncology 17 (6), 738-746, 20169912016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept